特朗普政府宣布重新分类医疗大麻：将其降级为“低风险药物”Trump Administration Moves to Reschedule Medical Marijuana as Less Dangerous Drug

尽管此次重新分类被视为重大突破，但其法律效力具有明确的界限。代理总检察长托德·布兰奇签署的命令明确指出，该举措并不等同于在联邦法律下将医疗或娱乐用大麻合法化。相反，它的重点在于调整监管框架，使联邦法律与许多已经建立医疗大麻体系的州政府政策更加协调。

Although this reclassification is viewed as a major breakthrough, its legal scope has clear boundaries. The order signed by Acting Attorney General Todd Blanche explicitly states that the move does not equate to the legalization of medical or recreational marijuana under federal law. Instead, it focuses on adjusting the regulatory framework to better align federal law with the policies of many states that have already established medical marijuana systems.

• 维持现状：大麻在联邦层面仍未实现全面合法化。
• 监管调整：改变了州政府授权的医疗大麻的监管和分类方式。
• 分类降级：将其从限制最严的类别移至“危险性较低”的类别。

• Status Quo: Marijuana remains not fully legalized at the federal level.
• Regulatory Adjustment: Changes how state-licensed medical marijuana is regulated and classified.
• Downgraded Classification: Moves it from the most restrictive category to a 'less-dangerous' one.

重新分类预计将为医疗大麻行业带来显著的实际利益，特别是在科学研究和财务运营方面。通过降低药物的管制等级，联邦政府实际上降低了医学研究人员获取和研究大麻产品的门槛。此前，由于大麻处于最严格的管制类别，研究人员面临着极其复杂的审批流程和严格的限制，这阻碍了对其药用价值的深入探索。

The reclassification is expected to bring significant practical benefits to the medical marijuana industry, particularly in scientific research and financial operations. By lowering the drug's control level, the federal government is effectively lowering the barriers for medical researchers to access and study cannabis products. Previously, because marijuana was in the most restrictive category, researchers faced extremely complex approval processes and strict limitations, which hindered in-depth exploration of its medicinal value.

在经济层面，这一转变还为相关企业提供了急需的税务减免。在原有的高强度管制下，大麻企业往往无法享受普通商业公司所拥有的联邦税收抵免和扣除。重新分类为“危险性较低”的药物后，这些州政府授权的运营商有望减轻税收负担，从而改善其财务状况并促进产业的可持续发展。

On an economic level, this shift also provides much-needed tax relief for related businesses. Under the previous high-intensity regulation, cannabis companies were often unable to enjoy the federal tax credits and deductions available to ordinary commercial firms. After being reclassified as a 'less-dangerous' drug, these state-licensed operators are expected to reduce their tax burdens, thereby improving their financial health and promoting sustainable industry development.

此次政策变更是大麻合法化倡导者多年努力的结果。长期以来，支持者一直批评联邦政府将大麻列入最严格管制类别的做法，认为这忽视了其已证实的医疗用途，并对那些在州法律框架下合法经营的企业造成了不公平的障碍。特朗普政府的这一举动被视为对这些社会诉求的迟到回应。

This policy change is the result of years of effort by marijuana legalization advocates. For a long time, supporters have criticized the federal government's practice of placing marijuana in the most restrictive regulatory category, arguing that it ignores proven medical uses and creates unfair obstacles for businesses operating legally under state law. This move by the Trump administration is seen as a belated response to these social demands.